• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期乳腺癌患者对积极多模式治疗的依从性。

Patient compliance with aggressive multimodal therapy in locally advanced breast cancer.

作者信息

Berger D, Braverman A, Sohn C K, Morrow M

机构信息

Department of Surgery, State University of New York Health Science Center, Brooklyn.

出版信息

Cancer. 1988 Apr 1;61(7):1453-6. doi: 10.1002/1097-0142(19880401)61:7<1453::aid-cncr2820610729>3.0.co;2-#.

DOI:10.1002/1097-0142(19880401)61:7<1453::aid-cncr2820610729>3.0.co;2-#
PMID:3345496
Abstract

This study of compliance was performed to determine whether a medically indigent population with breast carcinoma that has been neglected is an appropriate group for inclusion in an aggressive combined treatment program. After incisional biopsy, 28 locally advanced breast cancer (LABC) patients received two cycles of cytoxan, Adriamycin, 5-Fluorouracil, and tamoxifen (CAFT) followed by a simple mastectomy and level I axillary dissection. After surgery, patients received four additional cycles of CAFT alternating with three cycles of 15 Gy to the chest wall and regional lymphatics. Compliance was defined as overall compliance, the percentage of patients completing the protocol as described; and appointment compliance, the ratio between treatments or appointments attended versus those scheduled. Overall compliance was 75% (21 of 28 patients). The total number of appointments scheduled was 1054 (mean, 37 +/- 2), and the total attended was 965 (mean, 34 +/- 3), giving an appointment compliance rate of 91.7%. Compliance did not vary significantly with age, marital status, nationality, the presence of complications, or delay to diagnosis. Compliance did decrease significantly with time. There was 100% overall compliance at 2 months, 82% at 6 months, and 75% at 1 year. We conclude that although our patients had neglected their disease and were medically indigent, they were highly motivated patients once in therapy. This suggests that complex treatment regimens are feasible as well as effective for the treatment of LABC.

摘要

开展这项关于依从性的研究,旨在确定被忽视的患有乳腺癌的医疗贫困人群是否适合纳入积极的联合治疗方案。在进行切开活检后,28例局部晚期乳腺癌(LABC)患者接受了两个周期的环磷酰胺、阿霉素、5-氟尿嘧啶和他莫昔芬(CAFT)治疗,随后进行了单纯乳房切除术和I级腋窝淋巴结清扫术。术后,患者接受了另外四个周期的CAFT治疗,并与对胸壁和区域淋巴结进行三个周期的15 Gy放疗交替进行。依从性被定义为总体依从性,即按所述完成方案的患者百分比;以及预约依从性,即实际接受治疗或预约的次数与预定次数的比率。总体依从性为75%(28例患者中的21例)。预定的预约总数为1054次(平均,37±2次),实际参加的总数为965次(平均,34±3次),预约依从率为91.7%。依从性在年龄、婚姻状况、国籍、是否存在并发症或诊断延迟方面没有显著差异。依从性确实随时间显著下降。2个月时总体依从性为100%,6个月时为82%,1年时为75%。我们得出结论,尽管我们的患者忽视了他们的疾病且医疗贫困,但一旦接受治疗,他们积极性很高。这表明复杂的治疗方案对于LABC的治疗既可行又有效。

相似文献

1
Patient compliance with aggressive multimodal therapy in locally advanced breast cancer.局部晚期乳腺癌患者对积极多模式治疗的依从性。
Cancer. 1988 Apr 1;61(7):1453-6. doi: 10.1002/1097-0142(19880401)61:7<1453::aid-cncr2820610729>3.0.co;2-#.
2
Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial.局部晚期乳腺癌术前每周两次紫杉醇联合同步放疗,随后手术及术后基于阿霉素的化疗:一项I/II期试验
J Clin Oncol. 2003 Mar 1;21(5):864-70. doi: 10.1200/JCO.2003.06.132.
3
Promotion of patient appointment compliance in indigent pediatric medical care by use of a microcomputer.使用微型计算机促进贫困儿童医疗保健中患者预约的依从性
Ann Otol Rhinol Laryngol. 1989 Oct;98(10):755-60. doi: 10.1177/000348948909801001.
4
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.新辅助化疗后乳腺的病理肿瘤反应可预测腋窝淋巴结状态。
Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6.
5
Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.在乳腺钼靶筛查时代,对128例局部晚期乳腺癌患者采用含5-氟尿嘧啶、表柔比星和环磷酰胺的标准多药化疗进行多模式治疗:预后及治疗意义
Cancer. 1998 Sep 1;83(5):936-47.
6
Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.局部晚期乳腺癌伴同侧锁骨上转移联合治疗的长期结果:德克萨斯大学MD安德森癌症中心的经验。
J Clin Oncol. 2001 Feb 1;19(3):628-33. doi: 10.1200/JCO.2001.19.3.628.
7
Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction : An alternative treatment option for locally advanced breast cancer.新辅助放疗后行乳房切除术及即刻乳房重建:局部晚期乳腺癌的一种替代治疗选择。
Strahlenther Onkol. 2017 Apr;193(4):324-331. doi: 10.1007/s00066-017-1100-6. Epub 2017 Jan 25.
8
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.接受基于阿霉素新辅助化疗的乳腺癌患者原发性肿瘤及腋窝淋巴结完全病理缓解的临床病程
J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460.
9
Neoadjuvant chemotherapy in locally advanced breast cancer.局部晚期乳腺癌的新辅助化疗
J Coll Physicians Surg Pak. 2014 Nov;24(11):845-8.
10
[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].[局部晚期非炎性乳腺癌的联合化疗及术前放疗治疗:120例患者的最新结果]
Cancer Radiother. 2004 Jun;8(3):155-67. doi: 10.1016/j.canrad.2004.01.001.

引用本文的文献

1
Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer.非裔美国和白人早期乳腺癌女性对静脉化疗的依从性。
Cancer Nurs. 2015 Mar-Apr;38(2):89-98. doi: 10.1097/NCC.0000000000000139.
2
Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy.对于接受保乳治疗的乳腺癌患者而言,患者依从性对于实现等效的临床结果至关重要。
Ann Surg. 2000 Jun;231(6):883-9. doi: 10.1097/00000658-200006000-00013.
3
Variations in breast cancer treatment by patient and provider characteristics.
乳腺癌治疗因患者和医疗服务提供者特征而异。
Breast Cancer Res Treat. 1996;40(1):65-74. doi: 10.1007/BF01806003.
4
A biobehavioral model of cancer stress and disease course.癌症应激与病程的生物行为模型。
Am Psychol. 1994 May;49(5):389-404. doi: 10.1037//0003-066x.49.5.389.